Skip to content
MedsAcross

Medicine

Selegiline 5 mg tablet

Selegiline · Oral
Available on requestPrescription onlyUS FDAGeneric name

Selegiline 5 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions 15˚C to 30˚C (59˚F to 86˚F).

Key facts

Active ingredient (INN)
Selegiline
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Tablet
Route
Oral
Packs
60 tablets, 500 tablets, 4 tablets and 4 more
Manufacturers
ApotexA-S Medication SolutionsA2A Integrated PharmaceuticalsChartwell RXGolden State Medical Supplyi3 Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions 15˚C to 30˚C (59˚F to 86˚F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N04BD01 Selegiline
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 August 1996
Identifiers
RxCUI 859193DailyMed set ID c81e983b-455d-2e65-e053-2a95a90a3123, 189ac32d-28b4-47c5-9de6-318e502eff3b, f286c854-3b8c-44a8-b3b5-c828dbabb207 +3NDC 72319-006, 62135-694, 50090-2918 +3Application ANDA074672, ANDA074565, ANDA074871

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
60 tablet in 1 bottle73141-006-02A2A Integrated Pharmaceuticals15 March 2024
60 tablet in 1 bottle60505-3438-3Apotex6 July 1997
500 tablet in 1 bottle60505-3438-8Apotex6 July 1997
60 tablet in 1 bottle62135-694-60Chartwell RX6 May 2024
60 tablet in 1 bottle72319-006-02i3 Pharmaceuticals15 December 2021
4 tablet in 1 bottle50090-2918-0A-S Medication Solutions14 March 2017
60 tablet in 1 bottle60429-176-60Golden State Medical Supply2 April 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 5 June 1989Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Selegiline

Clinical summary

Selegiline is a monoamine oxidase inhibitor indicated for the treatment of adults with major depressive disorder (MDD). It is available as capsules, tablets and transdermal patches for oral use. MedsAcross supplies Selegiline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Selegiline

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Selegiline 5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.